Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2.

Gresko E, Roscic A, Ritterhoff S, Vichalkovski A, del Sal G, Schmitz ML.

EMBO J. 2006 May 3;25(9):1883-94. Epub 2006 Apr 6.

2.

How cells switch HIPK2 on and off.

Sombroek D, Hofmann TG.

Cell Death Differ. 2009 Feb;16(2):187-94. doi: 10.1038/cdd.2008.154. Epub 2008 Oct 31. Review.

3.

HIPK2-a therapeutical target to be (re)activated for tumor suppression: role in p53 activation and HIF-1α inhibition.

Nardinocchi L, Puca R, Givol D, D'Orazi G.

Cell Cycle. 2010 Apr 1;9(7):1270-5. Review.

PMID:
20234185
4.

HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis.

Hofmann TG, Glas C, Bitomsky N.

Bioessays. 2013 Jan;35(1):55-64. doi: 10.1002/bies.201200060. Epub 2012 Nov 21. Review.

PMID:
23169233
5.

Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.

Puca R, Nardinocchi L, Givol D, D'Orazi G.

Oncogene. 2010 Aug 5;29(31):4378-87. doi: 10.1038/onc.2010.183. Epub 2010 May 31. Review.

PMID:
20514025
6.

Updates on HIPK2: a resourceful oncosuppressor for clearing cancer.

D'Orazi G, Rinaldo C, Soddu S.

J Exp Clin Cancer Res. 2012 Aug 13;31:63. doi: 10.1186/1756-9966-31-63. Review.

7.

Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies.

Feng Y, Zhou L, Sun X, Li Q.

Oncotarget. 2017 Mar 21;8(12):20452-20461. doi: 10.18632/oncotarget.14723. Review.

8.

Homeodomain-Interacting Protein Kinase-2: A Critical Regulator of the DNA Damage Response and the Epigenome.

Kuwano Y, Nishida K, Akaike Y, Kurokawa K, Nishikawa T, Masuda K, Rokutan K.

Int J Mol Sci. 2016 Sep 27;17(10). pii: E1638. Review.

9.

HIPK2 modification code for cell death and survival.

Wook Choi D, Yong Choi C.

Mol Cell Oncol. 2014 Oct 29;1(2):e955999. doi: 10.1080/23723548.2014.955999. eCollection 2014 Apr-Jun. Review.

Supplemental Content

Support Center